Flooding & Sinkholes from Tropical Storm Debby

Tropical Storm Debby Insurance Claim Lawyers

Gilman Law LLP, a leading Florida law firm with more than 40 years of experience protecting the rights of consumers, is ready to assist individuals and businesses throughout Florida who suffered losses from Tropical Storm Debby. Gilman Law LLP is offering its assistance to all Florida residents and businesses impacted by Debby, including those in the hardest hit counties of Okaloosa, Calhoun, Bay, Franklin, Gulf, Liberty, Levy, Citrus, Hernando, Pasco, Pinellas, Highland, Hillsborough, Manatee, Sarasota, Charlotte, Walton, Wakulla, Jefferson, Dixie, Suwannee and Taylor. If you suffered a loss during Tropical Storm Debby, and need legal assistance with your insurance claim, please contact Gilman Law LLP today to discuss your legal rights.

Damage from Tropical Storm Debby

Flooding in Downtown Live Oak, Florida

Tropical Storm Debby deluged parts of northern Florida with as much as 25 inches of rain. The storm, which made landfall near Steinhatchee on Tuesday, June 26, was said to be weakening, but not before it spawned floods and tornadoes across the Panhandle and northern Florida. Tropical-storm warnings were in effect for 450 miles of coastline, from Mexico Beach in the Panhandle, to Englewood, south of Sarasota.

Parts of Interstate 10 in north Florida were closed due to flooding on a 50-mile stretch between Jacksonville and Tallahassee, and motorists were warned to use caution while traveling elsewhere on the interstate. A mandatory evacuation in Pasco County near Tampa Bay was ordered between the Anclote and Pithlachascotee rivers, where boats had to be used to help stranded residents, and 106 homes had been damaged. People in Wakulla County were being advised to stay in their homes, after Debby dumped more than 26 inches of rain. St. Marks, Florida saw 21 inches in just a two-day period, while major flooding was also reported in Stark and Pinellas counties.

In Suwannee County, which saw 16 inches of rain in a single 24 hour period, emergency management officials declared a voluntary evacuation of low-lying areas and locations near rivers, streams and creeks. Debby also left tens of thousands of people without power and forced the closure of key highways and bridges in the Tampa Bay area.

Sinkhole in Live Oak, Florida

By Tuesday, Tropical Storm Debby has spawned more than 20 tornadoes in Florida. In rural Highlands County, a young mother died when an apparent twister lifted her home off the ground, and tossed her and her son into the woods.

By Tuesday afternoon, Florida Governor Rick Scott had declared a state of emergency for the entire state. Meanwhile, forecasters were warning that Debby, though downgraded to a tropical depression, wasn’t finished wreaking havoc on Florida. Flash flood warnings were issued for parts of northern Florida and southern Georgia as Debby moved eastward. Debby was still dumping rain and could return to tropical storm strength when it finally exits Florida on the Atlantic coast. It was expected that some areas of northern Florida and southeast Georgia would see up to 15 inches of rain by Thursday. The system was also expected to produce more tornadoes before it finally left Florida.

Legal Help with Tropical Storm Debby Damage Claims

Long after Debby leaves Florida, residents and businesses will have to cope with the property damage, businesses losses and other consequences left behind in the storm’s wake. If you are unsure about your insurance policy, or you believe your insurance company may have mishandled or wrongly denied your Tropical Storm Debby damage claim, it is vital to get help from a Florida law firm experienced in dealing with tropical storms and hurricanes. Gilman Law LLP is ready now to provide legal assistance to anyone in Florida damaged by Tropical Storm Debby. To ensure you are protected, please complete our Free Consultation Form Online to speak with a property damage attorney today, or CALL TOLL FREE (888) 252-0048.

DePuy ASR Hip Replacement Lawsuit Update – DePuy ASR Lawsuit Status Conference Set For July 25, 2012

Gilman Law LLP, a national law firm representing individuals with DePuy ASR hip replacements, reports that on June 11, 2012, the Honorable David A. Katz, who is overseeing In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), currently underway in the U.S. District Court for the Northern District of Ohio, issued an order scheduling the next status conference in the DePuy ASR MDL for July 25, 2012.

Metal Hip Replacement Bellwether Trials In DePuy ASR Hip Lawsuit To Be Scheduled

A DePuy ASR Lawsuit status conference was previously held on June 5, 2012. Counsel updated the Judge on the discovery process, the production of documents, the status of depositions, and the coordination between the Federal DePuy ASR Hip Lawsuits and State DePuy ASR Hip Lawsuits. The DePuy ASR Hip Attorneys are actively working to schedule bellwether trials in the DePuy ASR Hip Implant Lawsuit. The first federal bellwether trial is expected to take place in Spring 2013. While the first state court trial is scheduled to take place in Nevada in December 2012. Another state court trial set for January 2013 in Maryland.

Gilman Law LLP Continues To File Metal-On-Metal Hip Replacement Lawsuits

In addition to actively filing DePuy hip replacement lawsuits in the DePuy ASR MDL, the hip lawyers at Gilman Law LLP are also filing lawsuits on behalf of individuals who have been implanted with certain metal-on-metal DePuy Pinnacle hip replacements, in In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“MDL No. 2244”). The firm is also investigating cases concerning Wright Medical Technology, Inc. metal hip implant Lawsuits involving the Wright Conserve hip replacements. These Wright metal hip implant lawsuits were recently consolidated in In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation (“MDL No. 2409”).

Metal Hip Implant Lawsuit Attorney

If you or a loved one has experienced metal hip implant side effects, you may be entitled to compensation for medical expenses, pain and suffering, lost wages, and further injuries. To learn more about how to file a DePuy Hip Implant Lawsuit, please contact our medical device attorneys:

About the DePuy Hip Implant Lawyers at Gilman Law LLP

Gilman Law LLP is a nationally recognized law firm representing individuals in complex injury cases in areas such as dangerous drugs, defective medical devices, DePuy Hip Implants, and other defective or dangerous consumer products.

Actos Lawsuit Update: Doctor Group Sours on Actos in Favor of Older Diabetes Meds

Further developments in the Actos lawsuit as the medical community appears to be growing cautious of Actos (Pioglitazone), Takeda Pharmaceutical’s best selling type-2 diabetes drug. Nearly a year after the U.S. Food & Drug Administration (FDA) and other regulators worldwide warned that Actos might be associated with an increased risk of bladder cancer, at least one U.S. doctor group has cautioned patients against it.

Last month, the American College of Physicians advised that patients steer clear of expensive, new diabetes drugs like Actos, and opt instead for more “tried and true” medications such as generic metformin. A new brochure put out by the College in cooperation with Consumer Reports points out that not only is generic metformin less expensive than Actos and other newer drugs, “it lowers blood sugar levels more than newer drugs do.” It also reduces “bad cholesterol,” while newer medications don’t.

Risks of Actos Bladder Cancer

Actos Bladder Cancer Lawsuit Update

Actos Bladder Cancer Lawsuit Update

Actos, made by Takeda Pharmaceuticals, is one of the best selling type-2 diabetes drugs in the world. But June of 2011, the FDA, as well as regulators in Europe and Canada, warned that studies had shown that long-term use of Actos can increase the risk of bladder cancer by as much as 40%. New warnings were added to the U.S. and Canadian labels for Actos. In France, however, the drug was actually recalled.

Since the Actos bladder cancer warnings were issued, Actos has been named in an avalanche of U.S. lawsuits. Some legal experts say Takeda may face as many as 10,000 claims over bladder cancer and other Actos side effects. Late last year, federal Actos lawsuits were consolidated in a multidistrict litigation and transferred to Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

About the Defective Drug Attorneys of Gilman Law LLP

Gilman Law LLP, a leading national law firm, represents victims of Actos side effects, including bladder cancer. Find out more about the Actos Lawsuit on our website for the Actos Bladder Cancer Lawsuit. If you or a loved one were injured by Actos, please contact our firm as follows for a free consultation and Actos Case Review:

Contact an Actos Bladder Cancer Attorney for an Actos Lawsuit

KBS REIT II Lawsuit: Recover KBS Real Estate Investment Trust (REIT) II Losses

KBS Real Estate Investment Trust II Lawsuit: If you invested in KBS REIT II, you may be able to recover your KBS REIT Losses, but you must act quickly! Call our REIT Attorneys Toll Free at (888) 252-0048 for a Free Consultation.

KBS REIT II Lawsuit and KBS REIT II Investigation

KBS REIT II Lawsuit

KBS REIT II Lawsuit

The REIT Investment Losses Division of Gilman Law LLP is seeking to represent investors who sustained financial losses in the KBS REIT II, a non-publicly traded real estate investment trust focused on commercial real estate, as well as KBS realty advisors, KBS-CMG, or other responsible parties. The KBS Real Estate Investment Trust II (KBS REIT 2) has seen a sharp drop in its valuation, and suspended redemptions. Most investors who purchased shares in the second REIT, KBS REIT II, did so believing that it was a safe and secure investment which would generate income without placing their principal at risk.

For over 40 years, the Investment Loss Attorneys at Gilman Law LLP have represented investors in all major aspects of public REIT lawsuits, non-traded REIT lawsuits, securities litigation, including stock manipulation, securities fraud, and shareholder rights violations. Our securities fraud lawyers are offering free legal consultations to any investor who suffered financial losses stemming from an investment in the KBS REIT 1. If you or someone you know purchased shares in KBS REIT II, and you’re concerned about the investment, we urge you to contact our securities fraud lawyers today by calling toll free at (888) 252-0048.

Legal Help for KBS REIT II Investors and KBS REIT II Shareholders

REIT Investors in KBS REIT 2 may be able to recover their losses by becoming part of a KBS REIT II Lawsuit or filing a FINRA arbitration claim. Gilman Law LLP has extensive experience representing investors in securities class action suits involving non-traded REITs similar to KBS REIT II, and has recovered more than one billion dollars for its clients. Our REIT lawyers are ready to assist investors who have suffered losses in the KBS REIT 2. For a free evaluation of your case, please complete our free consultation form online or CALL TOLL FREE (888) 252-0048.

Allscripts Healthcare Solutions Securities Fraud Lawsuit Deadline Approaching

Allscripts Healthcare Solutions Securities Fraud Lawsuit Deadline Approaching: Allscripts Healthcare Solutions Investors with Large Losses are Encouraged to Contact our Investment Losses Attorneys at (888) 252-0048.

About the Allscripts Healthcare Solutions Lawsuit

Allscripts Healthcare Securities Fraud Lawsuit

Allscripts Healthcare Securities Fraud Lawsuit

The Investment Losses and Securities Fraud Law Firm of Gilman Law LLP is investigating Allscripts Healthcare Solutions on behalf of shareholders and investors in the Allscripts Healthcare Solutions Securities Fraud Lawsuit for alleged violations of various securities laws. Concerned investors that have lost in excess of $400,000 are encouraged to contact our securities fraud attorneys to discuss your rights to recovery by calling Toll Free at (888) 252-0048, or completing our Free Consultation Form Online.

The lawsuit alleges that the Company failed to disclose that the process of developing a unified product offering after the merger of Allscripts-Misys Healthcare Solutions, Inc. and Eclypsis Corporation in August 2010 suffered debilitating setbacks, including major undisclosed schisms among the most senior levels of the Company, which ultimately resulted in the loss of key personnel and harmful upheaval in Company leadership, thereby violating the Securities Exchange Act of 1934. Additionally, the lawsuit alleges that a material portion of Allscripts’ revenue and net income was predicated on the successful integration of these systems, and substantial business relationships had been destroyed by the Company’s inability to make material progress in this area.

Legal Help for Allscripts Healthcare Solutions Investors and Shareholders

Allscripts Healthcare Investors with investment losses in excess of $400,000 that purchased shares of Allscripts’ common stock between November 9, 2010 and April 26, 2012 may be able to recover for Allscripts’ alleged securities law violations. Please contact our Experienced Securities Fraud Attorneys by calling our Investment Losses Law Firm Toll Free at (888) 252-0048 or by completing our Free Consultation Form Online.

The Experienced Investment Loss and Securities Fraud Attorneys at Gilman Law LLP have over 40 years of experience prosecuting securities fraud lawsuits, securities arbitration, investment fraud lawsuits, and other complex securities litigation.

Chesapeake Lawsuit Continues as United States Senate Calls for Fraud Probe

Chesapeake lawsuit on behalf of Shareholders continues as Chesapeake CEO states He is “deeply sorry” for recent Chesapeake scandal. Chesapeake Investors or Shareholders are encouraged to call (888) 252-0048 to discuss their potential rights for recovery or to join in the suit.

About the Chesapeake Lawsuit

Chesapeake Lawsuit Prompts U.S. Senate Fraud Probe

Chesapeake Lawsuit Prompts U.S. Senate Fraud Probe

Shareholders filed a Chesapeake Lawsuit recently concerning over $1 billion dollars in personal loans taken out over the past three years. These personal loans were previously undisclosed to shareholders and raised concerns that McClendon’s personal financial deals could compromise his fiduciary duty to Chesapeake. McClendon’s biggest personal lender, EIG Global Energy Partners, has also been a big financier to Chesapeake and the lawsuit says that some analysts believe EIG’s investors have been given favorable terms from the company on financing deals. The Chesapeake lawsuit seeks an order requiring the defendants to disclose all information about McClendon’s loans, and establish a method of reviewing his borrowings, among other things.

About the Chesapeake Scandal

Chesapeake CEO, Aubrey McClendon and eight other company executives are being accused of racking up $1.1 billion in loans against their own investments in Chesapeake Energy. These loans raise serious questions regarding conflicts of interest, and can frequently cloud the judgment of Chesapeake executives on issues ranging from cash flow, operating wells, and aggressive bargaining with financing deals. Recently, McClendon made his first public statements concerning these personal loans to investors in a conference call since news broke last month that he had taken out $1.1 billion in personal loans secured by personal interests in thousands of Chesapeake wells.

How To Join The Chesapeake Lawsuit

Chesapeake Investors that currently own shares of Chesapeake common stock are encouraged to contact the securities lawyers at Gilman Law LLP to join in the Chesapeake Lawsuit or to discuss their potential rights to recovery. Our team of experienced securities lawyers are offering free case reviews to investors in Chesapeake Energy. To receive a free case review, please complete our free consultation form online or call TOLL FREE at (888) 252-0048 to speak with one of our securities lawyers.

RPAI IPO Lawsuit: Retail Properties of America Lawsuit to Recover RPAI Losses

Real Estate Investors in Retail Properties of America, Inc. (RPAI), formerly Inland Western, may be able to recover their RPAI losses. Contact our securities attorneys toll free at (888) 252-0048 for a free consultation.

Retail Properties of America (RPAI) REIT Investigation

RPAI Inland Western REIT Losses Lawsuit

RPAI Inland Western REIT Losses Lawsuit

Did you sustain financial losses because of an investment in Retail Properties of America, Inc. (RPAI) REIT? In April 2012, early investors in the RPAI REIT, who had paid $10 for each of their shares, were caught off-guard by its initial public offering price of just $8 per share. Thanks to a stock split, some investors in Retail Properties of America may have lost more than 70% of their initial investment when it went public. Not surprisingly, some RPAI REIT shareholders now suspect they were taken advantage of, and are exploring legal avenues for recovering their losses.

If you lost money in the Retail Properties of America (RPAI) REIT, you may have an actionable claim to recover those investment losses through a RPAI REIT Lawsuit or FINRA arbitration. For over 40 years, the REIT Investment Loss Attorneys at Gilman Law LLP have represented investors in all major aspects of REIT lawsuits, non-traded REIT lawsuits, securities litigation, including stock manipulation, securities fraud, and shareholder rights violations. Our securities fraud lawyers are offering free legal consultations to any investor who suffered financial losses stemming from an investment in Retail Properties of America (RPAI) REIT. If you or someone you know purchased shares in the RPAI REIT, and you’re concerned about the investment, we urge you to contact our securities fraud lawyers today TOLL FREE at (888) 252-0048 or complete our free consultation form online for a free case review.

Inland Western / Retail Properties of America (RPAI) REIT IPO

Retail Properties of America, the nation’s third-largest shopping center REIT, holds property assets in 35 states. Prior to its April 5, 2012 IPO, the real estate investment trust was a non-traded REIT known as Inland Western REIT. According to some reports, Inland Western / Retail Properties of America, Inc. had been in trouble since 2005, when it stopped accepting capital. When the real estate market crashed in 2008, the RPAI REIT’s investment portfolio was extremely overvalued. As a result, dividend yields were cut from 6.4% to 1% by 2010. Unfortunately, like most non-traded REITs, Inland Western Properties was highly illiquid, leaving investors little choice but to hold onto their shares.

When the RPAI IPO was announced in March 2012, the initial valuation of the RPAI REIT’s shares at just $8 per share fell well below the expected price of $10 to $12. Even worse, the disappointing $8/share valuation was the result of a 10-to-1 reverse stock split and distribution plan. For investors who had originally bought into the Retail Properties of America REIT at $10/share, the actual split-adjusted value of the stock was less than $3 per share – a decline in value of more than 70%. According to some analysts, even when total dividend distributions of nearly $4 per share, accumulated over the full length of the investment period, are included in their returns, early investors were still only seeing about 80 cents back for every dollar they invested in the RPAI REIT.

Legal Help for Investors in Retail Properties of America REIT

The REIT Lawsuit Attorneys at Gilman Law LLP have extensive experience representing both individual and institutional investors in securities class action suits, and has recovered over a billion dollars for its clients. Our securities fraud lawyers are ready to assist investors who have suffered losses in the Retail Properties of America REIT. For a free evaluation of your case, please complete our free consultation form online for a free case review or CALL TOLL FREE (888) 252-0048.

KBS REIT I Lawsuit: How to Recover KBS Real Estate Investment Trust (REIT) Losses

KBS Real Estate Investment Trust Lawsuit: If you invested in KBS REIT I, you may be able to recover your KBS REIT Losses, but you must act quickly! Call our REIT Attorneys Toll Free at (888) 252-0048 for a Free Consultation.

KBS REIT Lawsuit and KBS REIT I Investigation

KBS REIT Lawsuit

KBS REIT Lawsuit

The REIT Investment Losses Division of Gilman Law LLP is seeking to represent investors who sustained financial losses in the KBS REIT I, a non-publicly traded real estate investment trust focused on commercial real estate, KBS realty advisors, KBS-CMG, or other responsible parties. The KBS Real Estate Investment Trust I (KBS REIT 1) has stopped paying distributions to its investors, seen a sharp drop in its valuation, and suspended redemptions. Most investors who purchased shares in the KBS REIT I did so believing that it was a safe and secure investment which would generate income without placing their principal at risk.

For over 40 years, the Investment Loss Attorneys at Gilman Law LLP have represented investors in all major aspects of public REIT lawsuits, non-traded REIT lawsuits, securities litigation, including stock manipulation, securities fraud, and shareholder rights violations. Our securities fraud lawyers are offering free legal consultations to any investor who suffered financial losses stemming from an investment in the KBS REIT 1. If you or someone you know purchased shares in this REIT, and you’re concerned about the investment, we urge you to contact our securities fraud lawyers today by calling toll free at (888) 252-0048.

KBS REIT I Valuation Drop

The offering price paid by most investors for KBS REIT I was $10 per share, and the KBS Real Estate Investment Trust had raised approximately $1.7 billion from real estate investors. Since most real estate investors purchased their shares, the KBS REIT I has seen a sharp drop in valuation. Most recently, on April 3, 2012, KBS Capital Advisors and the KBS REIT I told investor that it was cutting the value of the REIT to $5.16 per share, from $7.40, a drop of 29%. At the same time, KBS REIT 1 informed investors it was ceasing distributions “with the goal of managing the REIT’s debt obligations and cash flows, and attempting to maximize the total return to investors over time.” Previously, the KBS REIT I had been paying out annual distributions of 5.3%.

KBS REIT I has also reportedly suspended redemptions, meaning investors holding these share are stuck with them. Investors in non-traded REITs, like KBS REIT I, that have had redemption programs suspended may have difficulty selling their investments or suffer a serious loss on the secondary market. It is highly unlikely that buyers on the secondary market would be willing to pay anywhere near the appraised value of the KBS REIT 1 shares.

Legal Help for KBS REIT I Investors and KBS REIT I Shareholders

Investors in KBS REIT 1 may be able to recover their losses by becoming part of a KBS REIT Lawsuit or filing a FINRA arbitration claim. Gilman Law LLP has extensive experience representing both individual and institutional investors in securities class action suits involving non-traded REITs like KBS REIT I, and has recovered over a billion dollars for its clients. Our securities fraud lawyers are ready to assist investors who have suffered losses in the KBS REIT 1. For a free evaluation of your case, please complete our free consultation form online or CALL TOLL FREE (888) 252-0048.

What About KBS REIT II?

Real Estate Investors with KBS REIT II losses are also encouraged to contact the securities attorneys at Gilman Law LLP for a Free Consultation. Our firm is actively investigating claims for real estate losses in KBS REIT II as well as KBS REIT I. Please contact our firm toll free at (888) 252-0048 or complete our free consultation form online to receive a free KBS REIT II Case Review.

Yasmin Lawsuit Update-Bayer Yaz Lawsuit Settlement Update: Bayer To Pay $110M To Settle Many Yaz, Yasmin Claims

After continued mediation, Bayer is settling a portion of the Yaz, Yasmin Claims for at least $110M–roughly $220,000 per Yaz, Yasmin lawsuit. If you or a loved one has been experienced blood clots from use of Yaz Birth Control or Yasmin Birth Control, contact our Defective Yaz, Yasmin Attorneys today to get help filing a Yaz, Yasmin claim.

Terms Of The Yaz, Yasmin Settlement

New Developments in Yaz, Yasmin Settlement

New Developments in Yaz, Yasmin Settlement

In January 2012, the Honorable David Herndon, the presiding judge on many Bayer Yaz settlements, Yasmin birth control pill lawsuits, postponed the first scheduled Yaz trial and ordered the case to mediation. (Yaz, Yasmin Mediation Order).  Subsequently, Bayer officials agreed to pay at least $110 million to settle numerous Yasmin lawsuits over claims that its Yasmin birth-control pills caused blood clots in the first larger resolution of cases over the product since the parties went to mediation in an attempt to resolve claims of serious injuries from the use of Yaz birth-control pills and Yasmin birth-control pills.

Officials of Bayer, based in Leverkusen, Germany, agreed to pay an average of about $220,000 per case to resolve the claims that its Yasmin contraceptives and Yaz contraceptives caused sometimes fatal blood clots that can lead to heart attacks and strokes, according to individuals close to the settlement.

How To File A Bayer Yaz Lawsuit or Yasmin Lawsuit Update

If you or a loved one has experienced serious injuries or side effects from the use of Yaz birth control pills or Yasmin birth control pills, you are encouraged to contact our experienced Defective Drug Attorneys to get help filing a Yaz Claim or Yasmin Claim. If you have experienced serious blood clots from the use of Yaz birth control pills or Yasmin birth control pills, you may be entitled to up to $220,000 from the Yaz, Yasmin Settlement. Yaz Lawsuit Claims and Yasmin Lawsuit Claims are time sensitive, so do not delay. You may contact our Defective Drug Lawyers by calling Gilman Law LLP toll free at (888) 252-0048, or by completing our Yaz Claims Form and Yasmin Claims Form online for a free consultation and claim review.

 

The Latest News Yasmin Lawsuit Update, Bayer Yaz Settlement and Lawsuit

 

FDA Requires Yaz, Yasmin To Change Birth Control Label

New Yaz, Yasmin Label Required by FDA

New Developments in Yaz, Yasmin Lawsuit

New Developments in Yaz, Yasmin Lawsuit

On April 10, 2012, the U.S. Food and Drug Administration (FDA) announced that it was requiring Bayer, the maker of the allegedly defective birth control Yaz and Yasmin, to change its label for drospirenone-containing birth control pills (Yaz and Yasmin). The revised label includes the increased risk for developing dangerous blood clots.

The revised label is a result of previous studies have reported a three-fold increase in the risk of blood clots for drospirenone-containing birth control pills such as Yaz and Yasmin when compared to “older generation” birth control pills containing levonorgestrel or some other progestins. The advisory panel that met in December voted 21-5 that labeling on Bayer’s Yaz Birth Control Pill and Yasmin Birth Control Pill is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs. This prompted the FDA decision to revise the Yaz labeling and Yasmin labeling.

How To File A Yaz Claim or Yasmin Claim

In February 2012, Bayer settled approximately 70 Yaz claims and Yasmin claims involving plaintiffs who suffered blood clots, pulmonary embolisms, deep vein thrombosis or stroke while taking the birth control. The Experienced Defective Drug Attorneys of Gilman Law LLP are actively representing clients that have taken Yaz birth control or Yasmin birth control (drospirenone-containing birth control pills) and suffered serious injuries like the blood clots described above. If you or a loved one has suffered serious injuries from taking Yaz or Yasmin, please visit our Yaz/Yasmin Settlement Claims Center for a free consultation and case review.

Please Visit Our Yaz/Yasmin Settlement Claims Center for more information.